Navigation Links
International AIDS Society announces inaugural recipients of innovative HIV research awards
Date:7/13/2010

14 July 2010 (Geneva, Switzerland) The International AIDS Society (IAS) today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research (CNIHR). CNIHR grants, funded in partnership with the U.S. National Institutes of Health (NIH) and the NIH-supported Centers for AIDS Research (CFARs) are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

The CNIHR grants, which total $3.4 million (U.S. $) will fund research projects for up to two years. They are intended to advance the scientific understanding of HIV and to support new approaches to answer pressing scientific questions on issues such as the long-term survival of individuals with HIV infection and new approaches to the prevention of HIV transmission.

The 10 outstanding early stage researchers who have been selected for the initial grants come from a wide range of scientific disciplines and locations, including Australia, India, Mexico, South Africa, the United Kingdom, and the United States. Their research projects will be supported in collaboration with a CFAR institution with expertise in the grantee's area of research.

"The IAS is committed to supporting early stage investigators to bring much needed creative ideas to the HIV field," noted IAS President Dr Julio Montaner. "This innovative grant programme, which builds on the outcomes of the IAS-NIH 2009 scholarship programme introducing investigators to HIV research, has encouraged a number of exceptional early investigators to start a career in HIV research. In fact, 4 out of 10 CNIHR grantees received their first HIV training at the IAS-NIH 2009 scholarship programme."

"We are pleased to partner in this effort and are impressed by the diversity and the quality of candidates and research projects selected by the CNIHR grant programme," said NIH Office of AIDS Research Director, Dr. Jack Whitescarver. "In addition to the quality of research awarded, the breadth of these grants, which cover behavioral science, operations research, clinical science and basic science, along with projects on co-infections and AIDS-related illnesses, illustrates the importance of this grant programme, both for these research efforts and for future responses to HIV and AIDS."

"CFAR support for CNIHR is a true research collaboration," said Dr Michael Saag, Director of CFAR at the University of Alabama at Birmingham. "Funding is essential to supporting new scientific research, but so is collaboration and mentorship in the lab. By pairing grantees with a CFAR institution that specializes in their area of work, this programme takes a hands-on approach to ensuring that each research project funded is supported to produce the maximum benefit for HIV and AIDS research."

The grantees will be awarded scholarships to attend the XVIII International AIDS Conference in Vienna on 18-23 July 2010. A pre-conference seminar with leading scientists in the HIV field is designed to give grantees an overview on HIV science and to present their projects. It will be followed by daily training and networking sessions at the conference. Grantees will also attend outreach trips to clinics, HIV research institutions, and community organizations in Vienna. The award ceremony will take place on 23 July 2010 at AIDS 2010 at the XVIII International AIDS Conference at the Wien Messe Center in Vienna, Austria, at 8:45 a.m., immediately before that day's plenary session.

The CNIHR grants are awarded to:

Joseph Brown, Lecturer at London School of Hygiene and Tropical Medicine, for the project: Environmental health and HIV/AIDS in rural South Africa; who will be working with Charles van der Horst, UNC-Chapel Hill.

Denise Evans, Medical Doctor at the Clinical HIV Research Unit Medicine, University of the Witwatersrand, Johannesburg, for the project: Low-cost monitoring of HIV in resource-limited settings; who will be working with Christopher Mathews, UCSD CFAR Clinical Core/Director of UCSD Owen Clinic.

Kelly Lee, Assistant Professor at the University of Washington, for the project: Resolving the core protein skeleton of the HIV Env glycoprotein spike; who will be working with Shiu-Lok Hu, University of Washington, Washington National Primate Research Center.

Justine Mintern, Career Development Award Fellow at the Walter and Eliza Hall Institute of Medical Research, Melbourne, for the project: Combating Virus Infection with BST-2; who will be working with Bali Pulendran at Emory University.

Bradley Nilsson, Assistant Professor of Chemistry at the University of Rochester, for the project: Probing the Structure and Function of Semen Enhancer of HIV Infection; who will be working with Stephen Dewhurst, University of Rochester.

Clovis Palmer, Post Doctoral Fellow at Burnet Institute, Melbourne, Australia for the project: Novel approaches to study T cell metabolic dysfunction and immune response during HIV infection; who will be working with Joseph Mike McCune, UCSF.

Manu Platt, Assistant Professor at the Georgia Institute of Technology, for the project: Cardiovascular Disease & HIV-1: Vascular Biomechanics and Remodeling; who will be working with Roy Sutliff, Emory University.

Isabel Sada-Ovalle, Medical Researcher at the Instituto Nacional de Enfermedades Respiratorias, Mexico City, for the project: A novel pathway to induce killing of Mycobacterium tuberculosis in HIV+ patients; who will be working with Marylyn Martina Addo from Ragon Institute of MGH, MIT and Harvard.

Amit Singh, DBT/Wellcome Trust intermediate fellow from the International Center For Genetic Engineering and Biotechnology, New Delhi, for the project: Measuring intracellular redox potential of HIV-1 infected macrophages; who will be working with Dr. Rafi Ahmed, Emory Vaccine Ctr, Emory/ICGEB joint vaccine center, New Delhi.

Kim Woodrow, Assistant Professor at the University of Washington, for the project: Multifunctional nanoparticles as a combination microbicide to prevent mucosal transmission of HIV; who will be working with M. J. McElrath, Florian Hladik and Patrick Stayto, University of Washington/ Fred Hutchinson Cancer Center CFAR.


'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
41-227-100-822
International AIDS Society
Source:Eurekalert

Related biology news :

1. Touch Bionics announced as a winner in the Seventh Annual International Business Awards
2. Penn State to lead new international Center Of Excellence for malaria research
3. Tulane University will receive $11.2 million to lead international malaria research center
4. The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe
5. University of Manchester academics at international conference on geographic chemicals
6. International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit
7. International study identifies 12 new genetic risk factors for type 2 diabetes
8. Ascension Island extinct parsley fern rediscovered during International Year of Biodiversity
9. Sparks to receive Liebig Medal from International Union of Soil Sciences
10. Pollinators focus of international conference
11. 2010 International Conference on Emerging Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
Breaking Biology Technology: